Connecting you to content on EBSCOhost

Works in Clinical & Translational Immunology, 2024, Vol 13, Issue 6

Results: 4

1

Serum AZD7442 (tixagevimab–cilgavimab) concentrations and in vitroIC<sub>50</sub> values predict SARS‐CoV‐2 neutralising antibody titres.

Published in:

Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1517

By:

Clegg, Lindsay E;
Stepanov, Oleg;
Matthews, Sam;
White, Tom;
Seegobin, Seth;
Thomas, Steven;
Tuffy, Kevin M;
Någård, Mats;
Esser, Mark T;
Streicher, Katie;
Cohen, Taylor S;
Aksyuk, Anastasia A

Publication type:

Article

2

Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma.

Published in:

Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1515

By:

Zhong, Yu‐Min;
Chen, Ji;
Jiang, Jie;
Zhou, Wen‐Bin;
Gao, Ling‐Ling;
Zhang, Shui‐Lian;
Yan, Wen‐Qing;
Chen, Yu;
Zhang, Dong‐Kun;
Lu, Dan‐Xia;
Lv, Zhi‐Yi;
Xie, Zhi;
Huang, Ying;
Guo, Wei‐Bang;
Wang, Bin‐Chao;
Yang, Jin‐Ji;
Yang, Xue‐Ning;
Wu, Yi‐Long;
Zhang, Xu‐Chao

Publication type:

Article

3

Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial.

Published in:

Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1511

By:

Fokkens, Wytske J;
Bachert, Claus;
Hopkins, Claire;
Marglani, Osama;
Praestgaard, Amy;
Nash, Scott;
Deniz, Yamo;
Rowe, Paul J;
Sacks, Harry;
Jacob‐Nara, Juby A

Publication type:

Article

4

Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer.

Published in:

Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1516

By:

Yaghoubi Naei, Vahid;
Ivanova, Ekaterina;
Mullally, William;
O'Leary, Connor G;
Ladwa, Rahul;
O'Byrne, Ken;
Warkiani, Majid E;
Kulasinghe, Arutha

Publication type:

Article